Back to search
FDAFDA · Food and drugs·Recall number D-0223-2021

Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx only, US Compounding, 1270 Don's Lane, Conway, AR 72032

Published January 20, 2021 · Recall initiated: December 16, 2020

Summary

FDA records drug Class III recall D-0223-2021, published January 20, 2021 and initiated December 16, 2020. Recalling firm: US Compounding Inc; Status: Terminated; Reported quantity: 1534 syringes; Lot: Lot #: 20202010@6 BUD: 02/17/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
US Compounding Inc
Distributor
USA Nationwide
Lot
Lot #: 20202010@6 BUD: 02/17/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx only, US Compounding, 1270 Don's Lane, Conway, AR 72032 recalled?

Yes. FDA published recall D-0223-2021 on January 20, 2021. Reported hazard: Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.

What should I do if I have this product?

Voluntary: Firm initiated · Letter